Go back to the Europarl portal

Choisissez la langue de votre document :

  • bg - български
  • es - español
  • cs - čeština
  • da - dansk
  • de - Deutsch
  • et - eesti keel
  • el - ελληνικά
  • en - English (Selected)
  • fr - français
  • ga - Gaeilge
  • hr - hrvatski
  • it - italiano
  • lv - latviešu valoda
  • lt - lietuvių kalba
  • hu - magyar
  • mt - Malti
  • nl - Nederlands
  • pl - polski
  • pt - português
  • ro - română
  • sk - slovenčina
  • sl - slovenščina
  • fi - suomi
  • sv - svenska
Parliamentary questions
14 March 2017
E-001703-17
Question for written answer
to the Commission
Rule 130
Kostas Chrysogonos (GUE/NGL)

 Subject:  Risks from the use of antimicrobials in animals
 Answer(s) 

According to a report by experts from the European Food Safety Authority and the European Medicines Agency, the use of antimicrobials for preventing and treating bacterial infections in animals should be reduced, as antimicrobial resistance (AMR) is one of the most pressing public health issues in the world and the use of such substances in animals contributes to the problem(1). At the same time, they stress that there is a need for innovative solutions that find alternative ways to deal with animal health issues. Data collection on the consumption of antibiotics is considered key to the effectiveness of antimicrobial agents when it comes to public and animal health. They suggest vaccines, probiotics, prebiotics, bacteriophages and organic acids as possible alternatives, while they concluded that reducing the use of antimicrobial agents would lead to a general reduction in the resistance of bacteria carried by food products.

1. What is the Commission’s view on the suggestions produced by the European Food Safety Authority?

2. What are the Commission’s proposals as regards alternatives to antimicrobials?

3. What information does the Commission have on the ramifications for humans of long-term use of antimicrobials?

(1) http://www.efsa.europa.eu/en/press/news/170124-0?utm_source=EFSA+Newsletters&utm_campaign=e96a1f9175-HL_20170127sent&utm_medium=email&utm_term=0_7ea646dd1d-e96a1f9175-63805589

Original language of question: EL 
Last updated: 29 March 2017Legal notice